Kerrigan in Townhall: Smart Act is Bad Business, Bad for Health

By at 22 June, 2023, 11:57 am

SMART Prices Act is Not that Smart for Small Biotech Companies and Innovators

In a June 17 Townhall Op-ed, SBE Council president & CEO Karen Kerrigan writes about efforts in Congress to take a really bad and destructive policy and expand it even further. She notes that Senator Amy Klobuchar (D-MN) and several other lawmakers recently introduced the “Strengthening Medicare and Reducing Taxpayer Prices Act,” a bill they claim will help America’s seniors by imposing strict price caps on prescription drugs. Kerrigan observes:

“The so-called SMART Prices Act is anything but. The legislation would make it practically impossible for investors to finance drug development efforts, thus forcing many small biotech firms out of business. Ultimately, that outcome will deprive patients of lifesaving new treatments.”

Read the full Op-ed here.


News and Media Releases